Connection

Adolfo García-Sastre to Spike Glycoprotein, Coronavirus

Back to Details
This is a "connection" page, showing publications Adolfo García-Sastre has written about Spike Glycoprotein, Coronavirus.
Adolfo García-Sastre
Connection Strength
0.177
Spike Glycoprotein, Coronavirus
  1. Immunological imprinting of the antibody response in COVID-19 patients. Nat Commun. 2021 06 18; 12(1):3781.
    View in: PubMed
    Score: 0.105
  2. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate. EBioMedicine. 2020 Dec; 62:103132.
    View in: PubMed
    Score: 0.025
  3. An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike. Science. 2020 12 18; 370(6523):1473-1479.
    View in: PubMed
    Score: 0.025
  4. Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*. Angew Chem Int Ed Engl. 2021 04 19; 60(17):9467-9473.
    View in: PubMed
    Score: 0.006
  5. Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model. mBio. 2021 03 02; 12(2).
    View in: PubMed
    Score: 0.006
  6. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020 08 06; 182(3):685-712.e19.
    View in: PubMed
    Score: 0.006
  7. The intracellular sites of early replication and budding of SARS-coronavirus. Virology. 2007 May 10; 361(2):304-15.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.